Acacia Pharma Group PLC ACPH-BE:Euronext Brussels

*Data is delayed | EUR
Last | 5:35 PM CEST
0.794quote price arrow up+0.004 (+0.51%)
Volume
114,042
52 week range
0.70 - 2.78
Loading...
  • Open0.77
  • Day High0.795
  • Day Low0.765
  • Prev Close0.79
  • 52 Week High2.78
  • 52 Week High Date07/05/21
  • 52 Week Low0.70
  • 52 Week Low Date05/13/22

Key Stats

  • Market Cap76.18M
  • Shares Out99.71M
  • 10 Day Average Volume297,402.9
  • Dividend-
  • Dividend Yield-
  • Beta1
  • YTD % Change-37.58

KEY STATS

  • Open0.77
  • Day High0.795
  • Day Low0.765
  • Prev Close0.79
  • 52 Week High2.78
  • 52 Week High Date07/05/21
  • 52 Week Low0.70
  • 52 Week Low Date05/13/22
  • Market Cap76.18M
  • Shares Out99.71M
  • 10 Day Average Volume297,402.9
  • Dividend-
  • Dividend Yield-
  • Beta1
  • YTD % Change-37.58

RATIOS/PROFITABILITY

  • EPS (TTM)-0.45
  • P/E (TTM)-1.78
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acacia Pharma Group PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Acacia Pharma Group plc is a United Kingdom-based pharmaceutical company. The Company is focused on discovering, developing, and commercializing novel products. It operates through one reportable segment, being the development and commercialization of intellectual property through direct sale of the protected products in the United States. It provides medical treatments such as surgery, invasive procedures, or chemotherapy. Its product pipeline includes Barhemsys, Byfavo, and...
Scott Byrd
Non-Executive Independent Chairman of the Board
Michael Bolinder
Chief Executive Officer, Executive Director
Gary Gemignani
Chief Financial Officer
Address
The Officers Mess Business Centre
Royston Road
Cambridge
CB22 4QH
United Kingdom